Walter & Keenan Wealth Management’s Elevance Health ELV Stock Holding History

Walter & Keenan Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-516	Closed	-$265K	–	145
2022 Q4	$265K	Sell	516 -55	-10%	-$27.9K	0.1%	125
2022 Q3	$259K	Buy	571 +12	+2%	+$5.74K	0.11%	125
2022 Q2	$270K	Hold	559	–	–	0.11%	125
2022 Q1	$275K	Hold	559	–	–	0.09%	128
2021 Q4	$259K	Hold	559	–	–	0.08%	133
2021 Q3	$208K	Buy	559 +4	+0.7%	+$1.52K	0.07%	147
2021 Q2	$212K	Buy	+555	New	+$212K	0.07%	138

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Walter & Keenan Wealth Management's ELV Position: Q1 2023 in Review

Walter & Keenan Wealth Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 516 shares — an estimated $265K sold.

Walter & Keenan Wealth Management first reported a position in ELV in Q2 2021 and held it in 7 quarters. The position peaked at $275K in Q1 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

Walter & Keenan Wealth Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
Walter & Keenan Wealth Management sold 516 Elevance Health shares in Q1 2023, an estimated $265K.
Walter & Keenan Wealth Management first reported a position in Elevance Health in Q2 2021 and held it in 7 quarters.
Walter & Keenan Wealth Management's Elevance Health position peaked at $275K in Q1 2022.
1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Walter & Keenan Wealth Management's 13F filing for Q1 2023, filed 26 Apr 2023.